![](/img/cover-not-exists.png)
P-946 Why do non smokers with non-small cell lung cancer (NSCLC) who receive erlotinib have better clinical outcomes than smokers?
Clark, G., Cagnoni, P., Ptaszynski, M., Hamilton, M., Santabárbara, P., Christy-Bittel, J., Geiger, B., McCarthy, S., Onetto, N.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81439-4
Date:
July, 2005
File:
PDF, 149 KB
english, 2005